78 related articles for article (PubMed ID: 8981015)
1. Application of genetic screening in families with hereditary medullary thyroid carcinoma.
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():108-10. PubMed ID: 8981015
[TBL] [Abstract][Full Text] [Related]
2. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
[TBL] [Abstract][Full Text] [Related]
3. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
4. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
5. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
6. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
[TBL] [Abstract][Full Text] [Related]
7. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
[TBL] [Abstract][Full Text] [Related]
8. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
9. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary thyroid cancer can be cured by prophylactic surgery].
Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J
Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876
[TBL] [Abstract][Full Text] [Related]
12. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
Erdogan MF; Gursoy A
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers].
Høie J; Heimdal K; Nesland JM; Børmer O
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3249-52. PubMed ID: 11187163
[TBL] [Abstract][Full Text] [Related]
16. [Is immediate prophylactic thyroidectomy indispensable in familiar medullary thyroid carcinoma?].
Cañizo A; Fanjul M; Cerdá J; Menárguez J; Parente A; Laín A; Carrera N; Rodríguez-Arnao MD; Rodríguez-Sánchez A; Polo JR; Vázquez J
Cir Pediatr; 2008 Apr; 21(2):100-3. PubMed ID: 18624279
[TBL] [Abstract][Full Text] [Related]
17. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family].
Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L
Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576
[TBL] [Abstract][Full Text] [Related]
18. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
[TBL] [Abstract][Full Text] [Related]
20. [Surgical management of hereditary medullary carcinoma of the thyroid in patients with "RET" proto-oncogene mutation].
Calbo L; Spinelli C; Lazzara S; Melita P; Miccoli P
Chir Ital; 1998; 50(5-6):47-51. PubMed ID: 10392193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
